[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100571516":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":28,"locations":25,"responsibleParty":34,"collaborators":25,"id":36,"slug":37,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":41,"acronym":25,"eligibilityCriteria":42,"healthyVolunteers":38,"sex":43,"minAge":44,"maxAge":45,"enrollmentInfo":46,"targetDuration":25,"studyType":49,"phases":50,"briefSummary":52,"conditions":53,"keywords":25,"overallStatus":55,"whyStopped":25,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":25},{"fullName":5,"class":6},"Tehran University of Medical Sciences","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Iodine supplement","EXPERIMENTAL","In intervention group women will take 150 µg daily (one tablet per day, Tavan Institute, Tehran, Iran) that will be 2 months before starting the new in vitro fertilization (IVF) cycle.",[13],"Dietary Supplement: Iodine",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","Women will take a placebo tablet daily (containing white wheat flour, which is similar to iodine table in terms of size, shape, and color, Tavan Institute, Tehran, Iran) 2 months before starting the new IVF cycle.",[19],"Dietary Supplement: Placebo",[21,26],{"type":22,"name":23,"description":11,"armGroupLabels":24,"otherNames":25},"DIETARY_SUPPLEMENT","Iodine",[9],null,{"type":22,"name":15,"description":17,"armGroupLabels":27,"otherNames":25},[15],[29],{"name":30,"role":31,"phone":32,"phoneExt":25,"email":33},"Dr. Pantea Nazeri, Associate Professor","CONTACT","+98 21 61192357","nazeri.pantea@gmail.com\u002Fpnazeri@tums.ac.ir",{"type":35,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100571516","iodine-supplementation-and-fertility-parameters-100571516",false,"NCT06721273","Iodine Supplementation and Fertility Parameters","The Effect of Iodine Supplementation on Fertility Parameters in Women Experiencing Infertility","Inclusion Criteria:\n\n* Women with diminished ovarian reserve\n* Willingness to participate\n* Age range: 18 to 45 years\n* Women with a menstrual cycle of 21 to 42 days\n* Women who have not used any contraceptive methods in the past 12 months\n* Women who have not had in sexual intercourse for more than 2 months\n\nExclusion Criteria:\n\n* Unwillingness to participate\n* Women with polycystic ovary syndrome or endometriosis\n* Diagnosis of any thyroid disease\n* Use of any medication that affects the thyroid function\n* Use of dietary supplements containing iodine (excluding those considered in the present study)\n* Use of iodine-containing disinfectants","FEMALE","18 Years","45 Years",{"count":47,"type":48},230,"ESTIMATED","INTERVENTIONAL",[51],"NA","Iodine has been identified as a potential factor influencing female fertility during the childbearing years. The American Thyroid Association recommends that women attempting to conceive take a supplement containing 150 µg of iodine. However, no clinical trials have specifically examined the necessity of iodine supplementation in women experiencing infertility. Furthermore, no information is available on the optimal dose and duration of iodine supplementation to increase the chances of successful treatment in this group of women. Therefore, this study aims to investigate the effects of iodine supplementation on fertility parameters in infertile women.",[54],"Infertility (IVF Patients)","NOT_YET_RECRUITING","2024-12-03",{"date":58,"type":59},"2024-12-06","ACTUAL",{"date":61,"type":48},"2025-03-01",{"date":63,"type":48},"2027-03-01",{"name":5,"class":6}]